UAB CF Research and Translation Core Center - A Multicenter Randomized, Double-blind, Phase 2, Placebo Controlled Study to Determine the Safety and Efficacy of Ivacaftor (VX-770) for the Treatment of Chronic Obstructive Pulmonary Disease (The Multicenter Topic Trial).


Total Award Amount

  • 840450.00
  • Direct Costs

  • 699832.00
  • Sponsor Award Id

  • P30DK072482
  • Contributor

  • Mark Dransfield   Principal Investigator  
  • Steven Rowe   Investigator